(Updates with Merck's deal with UNICEF, Pfizer in Canada) Jan 19 (Reuters) - Countries are scrambling to buy the antiviral pills developed by Merck and Pfizer for adult COVID-19 patients. Merck signed an agreement https://www.reuters.com/business/healthcare-pharmaceuticals/merck-signs-supply-deal-with-unicef-3-mln-courses-covid-19-pill-2022-01-18 on Tuesday with the United Nations Children's Fund (UNICEF) to supply up to 3 million courses of its pill for distribution in more than 100 low- and middle-income countries upon regulatory authorizations. Here is an alphabetical list of other countries and their orders: Merck pill COUNTRY VOLUME PRICE TIMING OF SOURCE DELIVERY Australia 300,000 doses Belgium 10,000 courses Canada 500,000 courses EU Germany 80,000 doses Indonesia 600,000 - 1 December , million doses 2021 Ireland Italy 40,000 doses 40,000 [ + 12,000 doses in nL8N2TP0AJ] already week 3 distributed 2022 Japan 1.6 mln $1.2 courses billion Malaysia 150,000 courses Philippines 300,000 100-150 November courses pesos 2021 ($1.97-$2 .96) per pill Singapore South Korea 200,000 courses Switzerland 8,640 doses Jan 2022 "at the latest" Thailand 200,000 courses UK 2,230,000 early courses 2022 United 3,100,000 $700 per States courses course, total of $2.2 billion Pfizer pill COUNTRY VOLUME PRICE TIMING OF SOURCE DELIVERY Australia 500,000 https://bit.ly/3BTUQeL courses Belgium 10,000 courses Canada 1,000,000 30,400 doses courses already received, 120,000 to be delivered by end-March EU Germany Ireland Israel 100,000 Italy 200,000 February [ courses nL8N2TP0AJ] South Korea 70,000 courses Thailand UK 2,750,000 Early 2022 courses United 20,000,000 $530 per Expects 4 States courses course, mln courses $5.29 by end-Jan, billion 10 mln by for the June first 10 mln courses ordered ($1 = 85.4800 taka) (Reporting by Ina Kreutz, Agnieszka Gosciak and Federica Urso; Editing by Milla Nissi and Philippa Fletcher)
Our Standards: The Thomson Reuters Trust Principles.
